journal article·2023-12Open access

Directing cellular responses in a nanocomposite 3D matrix for tissue regeneration with nanoparticle-mediated drug delivery

Ezgi Özliseli, Sami Şanlıdağ, Behice Süren, Alaa Mahran, Marjaana Parikainen, Cecilia Sahlgren, Jessica M. Rosenholm

Abstract

Hydrogels play an important role in tissue engineering due to their native extracellular matrix-like characteristics, but they are insufficient in providing the necessary stimuli to support tissue formation. Efforts to integrate bioactive cues directly into hydrogels are hindered by incompatibility with hydrophobic drugs, issues of burst/uncontrolled release, and rapid degradation of the bioactive molecules. Skeletal muscle tissue repair requires internal stimuli and communication between cells for regeneration, and nanocomposite systems offer to improve the therapeutic effects in tissue regeneration. Here, the versatility of mesoporous silica nanoparticles (MSN) was leveraged to formulate a nanoparticle-hydrogel composite and to combine the benefits of controlled delivery of bioactive cues and cellular support. The tunable surface characteristics of MSNs were exploited to optimize homogeneity and intracellular drug delivery in a 3D matrix. Nanocomposite hydrogels formulated with acetylated or succinylated MSNs achieved high homogeneity in 3D distribution, with succinylated MSNs being rapidly internalized and acetylated MSNs exhibiting slower cellular uptake. MSN-hydrogel nanocomposites simultaneously allowed efficient local intracellular delivery of a hydrophobic model drug. To further study the efficiency of directing cell response, a Notch signaling inhibitor (DAPT) was incorporated into succinylated MSNs and incorporated into the hydrogel. MSN-hydrogel nanocomposites effectively downregulated the Notch signaling target genes, and accelerated and maintained the expression of myogenic markers. The current findings demonstrate a proof-of-concept in effective surface engineering strategies for MSN-based nanocomposites, suited for hydrophobic drug delivery in tissue regeneration with guided cues.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Bone Tissue Engineering Materials · Tissue Engineering and Regenerative Medicine · Graphene and Nanomaterials Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (90)

Show source-provided references
1. Tissue engineering: strategies, stem cells and scaffolds10.1111/j.1469-7580.2008.00878.x ↗
2. A decade of progress in tissue engineering10.1038/nprot.2016.123 ↗
3. From in vitro to in situ tissue engineering10.1007/s10439-014-1022-8 ↗
4. Biophysical and biochemical cues of biomaterials guide Mesenchymal stem cell behaviors
5. Obstacles and challenges for tissue engineering and regenerative medicine: Australian nuances10.1111/1440-1681.12899 ↗
6. Tissue repair and the dynamics of the extracellular matrix10.1016/j.biocel.2003.12.003 ↗
7. A comparative review of natural and synthetic Biopolymer composite scaffolds10.3390/polym13071105 ↗
8. Hydrogels for tissue engineering: addressing key design needs toward clinical translation
9. Current opportunities and challenges in skeletal muscle tissue engineering10.1002/term.190 ↗
10. Mimicking biological phenomena in hydrogel-based biomaterials to promote dynamic cellular responses10.1039/C5TB01045D ↗
11. Hydrogel-based drug delivery systems for poorly water-soluble drugs10.3390/molecules201119705 ↗
12. Biomimetic scaffolds for tissue engineering10.1002/adfm.201103083 ↗
13. Biologics vs. small molecules: drug costs and patient access10.1016/j.medidd.2020.100075 ↗
14. Insoluble drug delivery strategies: review of recent advances and business prospects10.1016/j.apsb.2015.07.003 ↗
15. Small molecules and small molecule drugs in regenerative medicine10.1016/j.drudis.2013.11.011 ↗
16. Hydrogels for hydrophobic drug delivery. Classification, synthesis and applications10.3390/jfb9010013 ↗
17. Emerging role of hydrogels in drug delivery systems, tissue engineering and wound Management10.3390/pharmaceutics13030357 ↗
18. Design considerations for mesoporous silica nanoparticulate systems in facilitating biomedical applications
19. Mesoporous silica nanoparticles in tissue engineering--a perspective10.2217/nnm.15.212 ↗
20. Nanoparticle–hydrogel superstructures for biomedical applications10.1016/j.jconrel.2020.05.041 ↗
21. Towards multifunctional, targeted drug delivery systems using mesoporous silica nanoparticles – opportunities & challenges10.1039/c0nr00156b ↗
22. Inhibiting Notch activity in breast cancer stem cells by glucose functionalized nanoparticles carrying γ-secretase inhibitors10.1038/mt.2016.42 ↗
23. Microfluidic-assisted Fabrication of dual-coated pH-Sensitive mesoporous silica nanoparticles for protein delivery10.3390/bios12030181 ↗
24. Chen · 2019 · vol. 11 · e1573
25. Recent advances in heterosilica-based Micro/nanomotors: designs, biomedical applications, and Future perspectives10.1021/acs.chemmater.1c00192 ↗
26. Engine-trailer-structured nanotrucks for efficient nano-Bio interactions and Bioimaging-guided drug delivery10.1016/j.chempr.2020.01.010 ↗
27. Emulsion-oriented assembly for Janus double-spherical mesoporous nanoparticles as biological logic gates10.1038/s41557-023-01183-4 ↗
28. Synthesis and surface modification of mesoporous silica nanoparticles and its application as carriers for sustained drug delivery10.3109/10717544.2013.838715 ↗
29. Mesoporous materials for drug delivery10.1002/anie.200604488 ↗
30. Multifunctional mesoporous silica nanoparticles as a universal platform for drug delivery10.1021/cm402592t ↗
31. Nanoparticle-hydrogel: a hybrid biomaterial system for localized drug delivery10.1007/s10439-016-1583-9 ↗
32. Design and development of hybrid hydrogels for biomedical applications: recent trends in anticancer drug delivery and tissue engineering10.3389/fbioe.2021.630943 ↗
33. Functional nanomaterials and 3D-printable nanocomposite hydrogels for enhanced cell proliferation and for the reduction of Bacterial Biofilm formation10.1021/acsami.1c13392 ↗
34. Injectable Graphene Oxide/hydrogel-based angiogenic gene delivery system for vasculogenesis and cardiac repair10.1021/nn5020787 ↗
35. A composite hydrogel containing mesoporous silica nanoparticles loaded with artemisia argyi extract for improving chronic wound healing
36. Paclitaxel-loaded hydroxyapatite/collagen hybrid gels as drug delivery systems for metastatic cancer cells10.1016/j.ijpharm.2013.02.002 ↗
37. Anti-inflammatory and repairing effects of mesoporous silica-loaded Metronidazole composite hydrogel on human dental pulp cells
38. A 3D printed bone tissue engineering scaffold composed of alginate dialdehyde-Gelatine reinforced by Lysozyme loaded cerium doped mesoporous silica-calcia nanoparticles10.1002/mabi.202200113 ↗
39. Biocomposite scaffolds containing chitosan/alginate/nano-silica for bone tissue engineering10.1016/j.colsurfb.2013.04.006 ↗
40. 2D and 3D cell cultures – a comparison of different types of cancer cell cultures
41. Three-dimensional cell culture: a Breakthrough in vivo10.3390/ijms16035517 ↗
42. Collagen-based biomaterials for tissue engineering10.1021/acsbiomaterials.2c00730 ↗
43. Natural-based biomaterials for peripheral nerve injury repair10.3389/fbioe.2020.554257 ↗
44. Collagen-based biomaterials for wound healing10.1002/bip.22486 ↗
45. Integrative genomic analyses on HES/HEY family: Notch-independent HES1, HES3 transcription in undifferentiated ES cells, and Notch-dependent HES1, HES5, HEY1, HEY2, HEYL transcription in fetal tissues, adult tissues, or cancer
46. Analyses in zebrafish embryos reveal that nanotoxicity profiles are dependent on surface-functionalization controlled penetrance of biological membranes10.1038/s41598-017-09312-z ↗
47. Mesoporous silica nanoparticles with redox-responsive surface linkers for charge-reversible loading and release of short oligonucleotides10.1039/c3dt53071j ↗
48. Design considerations for mesoporous silica nanoparticulate systems in facilitating biomedical applications10.2478/mesbi-2014-0001 ↗
49. A Fast and efficient ion-exchange procedure to remove surfactant molecules from MCM-41 materials10.1021/cm030633n ↗
50. Targeted modulation of cell differentiation in distinct regions of the gastrointestinal tract via oral administration of differently PEG-PEI functionalized mesoporous silica nanoparticles
51. Amino-functionalization of large-pore mesoscopically ordered silica by a one-step hyperbranching polymerization of a surface-grown polyethyleneimine10.1039/B607886A ↗
52. Shape engineering vs organic modification of inorganic nanoparticles as a tool for enhancing cellular internalization10.1186/1556-276X-7-358 ↗
53. W. Inam, R. Bhadane, R.N. Akpolat, R.A. Taiseer, S.K. Filippov, O.M.H. Salo-Ahen, J.M. Rosenholm, H. Zhang, Interactions between polymeric nanoparticles and different buffers as investigated by zeta potential measurements and molecular dynamics simulations, VIEW. n/a (n.d.) 20210009. https://doi.org/10.1002/VIW.20210009..
54. Mesoporous silica particles as drug delivery systems—the state of the art in loading methods and the recent progress in analytical techniques for monitoring these processes10.3390/pharmaceutics13070950 ↗
55. Active targeting of mesoporous silica drug carriers enhances γ-secretase inhibitor efficacy in an in vivo model for breast cancer10.2217/nnm.13.62 ↗
56. Amazing stability of phosphate-Quaternary amine interactions10.1021/pr8001595 ↗
57. PKCζ regulates Notch receptor routing and activity in a Notch signaling-dependent manner10.1038/cr.2014.34 ↗
58. Shape engineering vs organic modification of inorganic nanoparticles as a tool for enhancing cellular internalization10.1186/1556-276X-7-358 ↗
59. Labeling nanoparticles: dye leakage and altered cellular uptake10.1002/cyto.a.22853 ↗
60. A comparison of TEM and DLS methods to characterize size distribution of ceramic nanoparticles
61. Dynamic light scattering and transmission electron microscopy in drug delivery: a roadmap for correct characterization of nanoparticles and interpretation of results10.1039/D3MH00717K ↗
62. Size, stability, and porosity of mesoporous nanoparticles characterized with light scattering10.1186/s11671-017-1853-y ↗
63. 1,25(OH)2Vitamin D3 Stimulates myogenic differentiation by inhibiting cell proliferation and modulating the expression of promyogenic growth factors and Myostatin in C2C12 skeletal muscle cells10.1210/en.2011-0159 ↗
64. Current progress and challenges for skeletal muscle differentiation from human pluripotent stem cells using transgene-free approaches10.1155/2018/6241681 ↗
65. Toxicity and immunogenicity concerns related to PEGylated-micelle carrier systems: a review10.1080/14686996.2019.1590126 ↗
66. Simple modifications of Branched PEI lead to highly efficient siRNA carriers with low toxicity10.1021/bc800065f ↗
67. Asymmetry of nanoparticle inheritance upon cell division: effect on the coefficient of variation10.1371/journal.pone.0242547 ↗
68. Prolonged dye release from mesoporous silica-based imaging probes facilitates long-term Optical tracking of cell populations in vivo10.1002/smll.201503392 ↗
69. Quantitative considerations about the size dependence of cellular entry and excretion of colloidal nanoparticles for different cell types10.1007/s40828-021-00159-6 ↗
70. Controlled drug release for tissue engineering10.1016/j.jconrel.2015.08.049 ↗
71. Type I collagen can function as a reservoir of basic fibroblast growth factor10.1016/j.jconrel.2004.07.008 ↗
72. Silica nanoparticles as adhesives for biological tissues? Re-examining the effect of particles size, particle Shape, and the unexpected role of Base10.1002/ppsc.201700286 ↗
73. Glycation changes molecular organization and charge distribution in type I collagen fibrils10.1038/s41598-020-60250-9 ↗
74. Mesoporous silica materials: from physico-chemical properties to enhanced dissolution of poorly water-soluble drugs10.1016/j.jconrel.2017.07.047 ↗
75. On the intracellular release mechanism of hydrophobic cargo and its relation to the biodegradation behavior of mesoporous silica nanocarriers10.1016/j.ejps.2016.06.001 ↗
76. Preparation of curcumin loaded mesoporous silica nanoparticles: determining polarizability inside the mesopores10.1016/j.materresbull.2016.08.012 ↗
77. Factors affecting intracellular delivery and release of hydrophilic versus hydrophobic cargo from mesoporous silica nanoparticles on 2D and 3D cell cultures10.3390/pharmaceutics10040237 ↗
78. Challenges in 3D live cell imaging10.3390/photonics8070275 ↗
79. Establishment of a direct 2.5D organoid culture model using companion animal cancer tissues10.1016/j.biopha.2022.113597 ↗
80. Regulation of skeletal myogenesis by Notch10.1016/j.yexcr.2010.05.002 ↗
81. Notch signaling in development, tissue Homeostasis, and disease10.1152/physrev.00005.2017 ↗
82. Rational evaluation of human serum albumin coated mesoporous silica nanoparticles for xenogenic-free stem cell therapies10.1016/j.colsurfa.2020.124945 ↗
83. O2 regulates skeletal muscle progenitor differentiation through phosphatidylinositol 3-kinase/AKT signaling10.1128/MCB.05857-11 ↗
84. A three-dimensional culture model of reversibly Quiescent myogenic cells10.1155/2019/7548160 ↗
85. Prostaglandin EP2 receptor downstream of Notch signaling inhibits differentiation of human skeletal muscle progenitors in differentiation conditions10.1038/s42003-020-0904-6 ↗
86. Type I collagen promotes the migration and myogenic differentiation of C2C12 myoblasts via the release of interleukin-6 mediated by FAK/NF-κB p65 activation10.1039/C9FO01346F ↗
87. Transient gamma-secretase inhibition accelerates and enhances fracture repair likely via Notch signaling modulation10.1016/j.bone.2014.12.007 ↗
88. Transient inactivation of Notch signaling synchronizes differentiation of neural progenitor cells10.1016/j.ydbio.2007.01.001 ↗
89. Inhibition of Notch signaling in human embryonic stem cell–derived neural stem cells delays G1/S phase transition and accelerates neuronal differentiation in vitro and in vivo10.1002/stem.408 ↗
90. Therapeutic targeting of Notch signaling: from cancer to inflammatory disorders10.3389/fcell.2021.649205 ↗